Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

British Journal of Cancer
Amado J ZuritaJohn V Heymach

Abstract

Sunitinib is approved worldwide for treatment of advanced pancreatic neuroendocrine tumours (pNET), but no validated markers exist to predict response. This analysis explored biomarkers associated with sunitinib activity and clinical benefit in patients with pNET and carcinoid tumours in a phase II study. Plasma was assessed for vascular endothelial growth factor (VEGF)-A, soluble VEGF receptor (sVEGFR)-2, sVEGFR-3, interleukin (IL)-8 (n=105), and stromal cell-derived factor (SDF)-1α (n=28). Pre-treatment levels were compared between tumour types and correlated with response, progression-free (PFS), and overall survival (OS). Changes in circulating myelomonocytic and endothelial cells were also analysed. Stromal cell-derived factor-1α and sVEGFR-2 levels were higher in pNET than in carcinoid (P=0.003 and 0.041, respectively). High (above-median) baseline SDF-1α was associated with worse PFS, OS, and response in pNET, and high sVEGFR-2 with longer OS (P⩽0.05). For carcinoid, high IL-8, sVEGFR-3, and SDF-1α were associated with shorter PFS and OS, and high IL-8 and SDF-1α with worse response (P⩽0.05). Among circulating cell types, monocytes showed the largest on-treatment decrease, particularly CD14+ monocytes co-expressing VEGFR...Continue Reading

References

Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T A PartanenK Alitalo
Jul 16, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Donna E HanselAnirban Maitra
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yu TakahashiNobuyoshi Hiraoka
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anat Norden-ZfoniJohn V Heymach
Oct 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·John M L EbosRobert S Kerbel
Jul 8, 2008·Endocrine-related Cancer·Ulrich-Frank PapeBertram Wiedenmann
Jul 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew H KulkeCharles S Fuchs
Jul 25, 2008·Nature Reviews. Cancer·Gabriele Bergers, Douglas Hanahan
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrizia MancusoFrancesco Bertolini
Jan 15, 2010·Endocrine-related Cancer·Yvonne ArvidssonOla Nilsson
Apr 9, 2010·Clinical Pharmacology and Therapeutics·A LindauerU Jaehde
Jan 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew H KulkeJames C Yao
Feb 11, 2011·The New England Journal of Medicine·Eric RaymondPhilippe Ruszniewski
Mar 24, 2011·The Cancer Journal·Armin GergerHeinz-Josef Lenz
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco PanzutoMassimo Falconi
Oct 14, 2011·The Journal of Clinical Endocrinology and Metabolism·James C YaoKjell E Öberg
Feb 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chiara CremoliniAlfredo Falcone
Sep 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Miguel F SanmamedIgnacio Melero
Sep 19, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Omar Abdel-Rahman

❮ Previous
Next ❯

Citations

Oct 7, 2015·Experimental and Molecular Pathology·Vladimir V NovoselovAlexander N Orekhov
Oct 19, 2016·Nature Reviews. Clinical Oncology·Mark KiddKjell Öberg
Nov 11, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P GajateE Grande
Feb 15, 2018·Endocrine-related Cancer·Kosmas DaskalakisPeter Stålberg
Jan 9, 2019·ESC Heart Failure·Michael LichtenauerUta C Hoppe
Jan 8, 2019·Endocrine-related Cancer·Aura D Herrera-MartínezRichard A Feelders
Apr 27, 2019·Endocrine Connections·Kosmas DaskalakisAnna Koumarianou
Jan 18, 2019·Oncotarget·Paula Jiménez-FonsecaEnrique Grande
Jun 22, 2017·Targeted Oncology·Diana MartinsUNKNOWN IEO ENETS Center of Excellence for GEP NETs
Jun 2, 2020·World Journal of Gastroenterology : WJG·Zu-Yi MaBao-Hua Hou
Apr 27, 2018·Molecular Cancer Therapeutics·Michalis MastriJohn M L Ebos
Aug 10, 2021·Frontiers in Endocrinology·Elisa GiannettaAntongiulio Faggiano
Jan 31, 2019·Neuroendocrinology·Mauro CivesFranco Silvestris

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
flow cytometry

Clinical Trials Mentioned

NCT00056693

Software Mentioned

SAS

Related Concepts

Related Feeds

Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Carcinoma, Islet Cell

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arises in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Carcinoma here.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.